Reona Sowers
Family Medicine · Neosho, MONPI 1154946879
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,956, 6.9 times the $282 reported in 2023.
Across 176 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$703
- AbbVie$403
- Novo Nordisk$301
- Pfizer$230
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$194
- Lilly USA, LLC$185
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,190100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $703 |
| AbbVie | 28 | $403 |
| Novo Nordisk | 18 | $301 |
| Pfizer | 21 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $194 |
| Lilly USA, LLC | 12 | $185 |
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| GSK | 6 | $121 |
| Exact Sciences | 7 | $110 |
| Johnson & Johnson | 5 | $99 |
| Lundbeck LLC | 5 | $91 |
| Boehringer Ingelheim | 5 | $90 |
| Globus Medical | 2 | $84 |
| Sumitomo Pharma America, Inc. | 4 | $63 |
| Astellas Pharma US Inc | 2 | $62 |
| Dexcom, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Neurelis, Inc. | 1 | $30 |
| Amgen | 2 | $29 |
| Edwards Lifesciences | 1 | $29 |
| Dynavax Technologies Corporation | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Novartis | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,190 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 26 | $35,185 |
| MounjaroTirzepatide | 18 | $30,020 |
| TrulicityDulaglutide | 13 | $29,007 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $23,432 |
| VraylarCariprazine Hcl | 13 | $23,150 |
| JardianceEmpagliflozin | 15 | $18,043 |
| JanuviaSitagliptin Phosphate | 19 | $18,041 |
| TrintellixVortioxetine Hydrobromide | 18 | $11,583 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,809 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,645 |
| Gabapentin | 75 | $1,049 |
| Duloxetine Hcl | 14 | $1,013 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $922 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $643 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $632 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $185 | $59,02731 claims |
| Novo NordiskOzempic | $301 | $35,18526 claims |
| AstraZenecaBreztri Aerosphere | $703 | $23,43230 claims |
| AbbVieVraylar | $403 | $23,15013 claims |
| Boehringer IngelheimJardiance | $90 | $18,04315 claims |
| GSKTrelegy Ellipta | $121 | $10,80917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Neosho
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.